| Literature DB >> 24258112 |
Lei Cui1, Rong Xie, Shenchun Dang, Qing Zhang, Shengfa Mao, Jixiang Chen, Jianguo Qu, Jianxin Zhang.
Abstract
NOV, a member of the CCN (Cyr61, CTGF and NOV) family, is involved in diverse biological processes, such as cell adhesion, proliferation and angiogenesis. However, its function in pancreatic cancer remains poorly understood. Here, we found that the expression of NOV was up-regulated in pancreatic cancer tissues. Moreover, over-expression of NOV in pancreatic cancer cells promoted cell proliferation and migration, while knock down the expression of NOV impaired the tumorigenecity of pancreatic cancer cells in vitro and in vivo. Mechanistically, NOV induced epithelial-mesenchymal transition (EMT) and regulated the expression of multiple EMT marker. Taken together, our study suggested the important role of NOV in pancreatic cancer and NOV might be an important therapeutic target.Entities:
Mesh：
Substances：
Year: 2013 PMID： 24258112 DOI： 10.1007/s13277-013-1418-3
Source DB: PubMed Journal: Tumour Biol ISSN： 1010-4283